Go Pro

Citadel Advisors LLC Acquires Shares of 120,000 Kardigan, Inc. $KARD

Key Points

  • Citadel Advisors initiated a 120,000-share position in Kardigan worth approximately $2.86 million, while several other institutional investors also disclosed new stakes during the second quarter.
  • Kardigan insiders made significant purchases: Director Paul L. Berns and Arch Venture Partners XIII each acquired 1.25 million shares at $16 per share, investing $20 million apiece.
  • KARD opened at $21.60, after reporting a quarterly loss of $4.61 per share. Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and a $42.25 average price target, despite one downgrade to “sell.”
  • MarketBeat previews the top five stocks to own by October 1st.

Citadel Advisors LLC bought a new stake in shares of Kardigan, Inc. (NASDAQ:KARD - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 120,000 shares of the company's stock, valued at approximately $2,862,000. Citadel Advisors LLC owned about 0.13% of Kardigan at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in KARD. Jupiter Topco LLC purchased a new stake in Kardigan during the second quarter worth about $17,715,000. Montanova Capital LLC purchased a new stake in shares of Kardigan during the 2nd quarter worth approximately $9,540,000. Bank of New York Mellon Corp purchased a new stake in shares of Kardigan during the 2nd quarter worth approximately $9,010,000. Braidwell LP bought a new stake in shares of Kardigan in the 2nd quarter worth approximately $7,155,000. Finally, Bank of America Corp DE bought a new stake in shares of Kardigan in the 2nd quarter worth approximately $1,283,000.

Insider Buying and Selling at Kardigan

In related news, Director Paul L. Berns purchased 1,250,000 shares of Kardigan stock in a transaction dated Monday, June 22nd. The stock was bought at an average cost of $16.00 per share, for a total transaction of $20,000,000.00. Following the completion of the transaction, the director owned 15,042,035 shares in the company, valued at $240,672,560. This trade represents a 9.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Arch Venture Partners Xiii, Ll acquired 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, June 22nd. The shares were bought at an average price of $16.00 per share, for a total transaction of $20,000,000.00. Following the completion of the purchase, the director owned 15,042,035 shares in the company, valued at $240,672,560. This trade represents a 9.06% increase in their position. The SEC filing for this purchase provides additional information.

Kardigan Stock Performance

Shares of KARD stock opened at $21.60 on Wednesday. The company's 50 day simple moving average is $21.54. Kardigan, Inc. has a 12 month low of $16.25 and a 12 month high of $27.00.

Kardigan (NASDAQ:KARD - Get Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($4.61) EPS for the quarter. As a group, research analysts forecast that Kardigan, Inc. will post -5.14 EPS for the current year.

Analyst Upgrades and Downgrades

KARD has been the subject of several research reports. Wall Street Zen lowered Kardigan from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. JPMorgan Chase & Co. lowered their target price on Kardigan from $51.00 to $46.00 and set an "overweight" rating on the stock in a research note on Tuesday, August 25th. Jefferies Financial Group started coverage on Kardigan in a research report on Monday, July 13th. They set a "buy" rating and a $40.00 price target on the stock. Leerink Partners initiated coverage on Kardigan in a research note on Monday, July 13th. They set an "outperform" rating and a $37.00 price target for the company. Finally, Zacks Research raised Kardigan to a "hold" rating in a report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Kardigan currently has a consensus rating of "Moderate Buy" and a consensus price target of $42.25.

Read Our Latest Stock Report on KARD

Kardigan Profile

(Free Report)

Kardigan Inc is a clinical-stage precision therapeutics company developing medicines which target the root cause of specific cardiovascular diseases. Kardigan Inc is based in South San Francisco, California.

See Also

Want to see what other hedge funds are holding KARD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kardigan, Inc. (NASDAQ:KARD - Free Report).

Institutional Ownership by Quarter for Kardigan (NASDAQ:KARD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kardigan Right Now?

Before you consider Kardigan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kardigan wasn't on the list.

While Kardigan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines